360773-84-8

Basic information

• Product Name: t-Butyl 1-(4-bromophenyl)cyclopropylcarbamate
• Synonyms: 1-(N-BOC-Amino)-1-(4-bromophenyl)cyclopropane;t-Butyl 1-(4-bromophenyl)cyclopropylcarbamate;tert-Butyl (1-(4-broMophenyl)cyclopropyl)carbaMate;[1-(4-Bromo-phenyl)-cyclopropyl]-carbamic acid tert-butyl ester;tert-Butyl N-[1-(4-bromophenyl)cyclopropyl]carbamate;tert-Butyl (1-(4-bromophenyl);Carbamic acid, N-[1-(4-bromophenyl)cyclopropyl]-, 1,1-dimethylethyl ester
• CAS NO: 360773-84-8
• Molecular Formula: C₁₄H₁₈BrNO₂
• Molecular Weight: 312.20222
• Mol File: 360773-84-8.mol
• Article Data: 17

Chemical Properties

• Boiling Point: 385.2±31.0 °C(Predicted)
• Appearance: /
• Density: 1.37±0.1 g/cm3(Predicted)
• Storage Temp.: Room temperature.
• PKA: 11.94±0.20(Predicted)
• CAS DataBase Reference: t-Butyl 1-(4-bromophenyl)cyclopropylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: t-Butyl 1-(4-bromophenyl)cyclopropylcarbamate(360773-84-8)
• EPA Substance Registry System: t-Butyl 1-(4-bromophenyl)cyclopropylcarbamate(360773-84-8)

Safety Data

• Hazardous Substances Data: 360773-84-8(Hazardous Substances Data)

Usage

General Description

t-Butyl 1-(4-bromophenyl)cyclopropylcarbamate is a chemical compound that belongs to the carbamate ester family. It is derived from the reaction between t-butyl isocyanate and 1-(4-bromophenyl)cyclopropanol. t-Butyl 1-(4-bromophenyl)cyclopropylcarbamate is used in organic synthesis and pharmaceutical research as a potential pharmaceutical intermediate. It is a white solid with a molecular formula of C13H17BrNO2 and a molar mass of 288.189 g/mol. t-Butyl 1-(4-bromophenyl)cyclopropylcarbamate has potential applications in the development of pharmaceuticals due to its structural features and reactivity.

Upstream product

• 952289-92-8 1-(4-bromophenyl)cyclopropan-1-amine hydrochloride 
• 24424-99-5 di-tert-butyl dicarbonate 
• 133017-10-4 Butyl 2-(4-bromophenyl)acetate 
• 345965-54-0 1-(4-bromophenyl)-cyclopropylamine 
• 345965-52-8 1-(4-bromophenyl)cyclopropanecarboxylic acid 
• 75-65-0 tert-butyl alcohol 

Downstream Products

• 1313441-88-1 tert-butyl N-[1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropyl]carbamate 
• 1374261-40-1 1-[4-(2-phenyl-9H-imidazo[1,2-d]pyrido[2,3-b][1,4]benzodiazepin-3-yl)phenyl]cyclopropanamine 
• 1374263-34-9 tert-butyl {1-[4-(2-phenyl-9H-imidazo[1,2-d]pyrido[2,3-b][1,4]benzodiazepin-3-yl]phenyl}cyclopropyl}carbamate 
• 952289-95-1 4-(1-(4-bromophenyl)cyclopropyl)morpholine 
• 1380754-94-8 methyl 4-(1-(5-chloro-2-(3-((2,4-difluorophenyl)amino)azetidin-1-yl)nicotinamido)cyclopropyl)benzoate 
• 1380754-92-6 methyl 4-(1-(5-chloro-2-(3-((4-fluoro-2-methylphenyl)amino)azetidin-1-yl)nicotinamido)cyclopropyl)benzoate 
• 1380754-78-8 methyl 4-(1-(5-chloro-2-(3-(3-fluorobenzoyl)azetidin-1-yl)nicotinamido)cyclopropyl)benzoate 
• 1380754-68-6 methyl 4-(1-(5-chloro-2-(3-(3-(piperazin-1-yl)phenoxy)azetidin-1-yl)nicotinamido)cyclopropyl)benzoate 
• 1380754-59-5 methyl 4-(1-(5-chloro-2-(3-(3-fluorophenoxy)azetidin-1-yl)nicotinamido)cyclopropyl)benzoate 
• 1380754-47-1 methyl 4-(1-(2-(2-benzylpyrrolidin-1-yl)-5-chloronicotinamido)cyclopropyl)benzoate 
• 1380754-44-8 methyl 4-(1-(5-chloro-2-(2-phenylpyrrolidin-1-yl)nicotinamido)cyclopropyl)benzoate 
• 1380750-32-2 4-(1-(2-(2-benzylpyrrolidin-1-yl)-5-chloronicotinamido)cyclopropyl)benzoic acid 

Relevant articles and documents

NOVEL INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.

Synthesis method of (4-(1-((tert-butoxycarbonyl)amino)cyclopropyl)phenyl)borate

The invention discloses a synthesis method of (4-(1-((tert-butoxycarbonyl)amino)cyclopropyl)phenyl)borate. The preparation method comprises the following steps: S1, dissolving a compound A with a massof 1.5-200 g and a volume of 5-900 mmol in 20-2000 mL o

SUBSTITUTED PYRIMIDINES AS INHIBITORS OF HIF PROLYL HYDROXYLASE

The present invention concerns compounds of Formula I that inhibit HIF prolyl hydroxylase, their use for enhancing endogenous production of erythropoietin, and for treating conditions associated with reduced endogenous production of erythropoietin such as